Antitumor Activity and Bystander Effect of Adenovirally Delivered Tissue Inhibitor of Metalloproteinases-3-Reference-Cited by-同舟云学术

Antitumor Activity and Bystander Effect of Adenovirally Delivered Tissue Inhibitor of Metalloproteinases-3

Published:2002-06 Issue:6 Volume:5 Page:705-715
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Ahonen Matti,Ala-Aho Risto,Baker Andrew H.,George Sarah J.,Grénman Reidar,Saarialho-Kere Ulpu,Kähäri Veli-Matti

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference47 articles.

1. Regulation of matrix metalloproteinase expression in tumor invasion;Westermarck;FASEB J.,1999

2. Matrix metalloproteinases in human melanoma;Hofmann;J. Invest. Dermatol.,2000

3. Collagenase immunolocalization studies of cutaneous secondary melanomas;Woolley;Br. J. Cancer,1980

4. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value;Väisänen;J. Pathol.,1996

5. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin;Van den Oord;Am. J. Pathol.,1998

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promoter DNA methylation patterns in oral, laryngeal and oropharyngeal anatomical regions are associated with tumor differentiation, nodal involvement and survival;Oncology Letters;2024-01-08

2. A top-down approach to uncover the hidden ligandome of low-density lipoprotein receptor-related protein 1 in cartilage;Matrix Biology;2022-09

3. Uncovering the ligandome of low-density lipoprotein receptor-related protein 1 in cartilage: a top-down approach to identify therapeutic targets;2022-03-02

4. The Role of p53 in Progression of Cutaneous Squamous Cell Carcinoma;Cancers;2021-09-07

5. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis;Theranostics;2019